Skip to content

Effect of Total Sleep Deprivation on Vascular Function

Effect of Total Sleep Deprivation on Vascular Function

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04535219
Enrollment
23
Registered
2020-09-01
Start date
2021-07-11
Completion date
2022-08-02
Last updated
2023-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Deprivation

Brief summary

Insufficient sleep is associated with an increased risk for cardiovascular disease. The causal mechanisms are currently unknown, but may include endothelial dysfunction. The purpose of this study is to examine the influence of sex and aging on the effects of total sleep deprivation on vascular function and whether exercise training attenuates these effects.

Interventions

OTHERExercise

60 minutes of moderate-intensity treadmill exercise (70% of maximal heart rate determined from the maximal graded exercise test)

OTHERSupervised Total Sleep Deprivation

Laboratory-monitored total sleep deprivation

Sponsors

University of Florida
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Males and females * 20 to 30 and 50 to 60 years of age * Females will be eumenorrheic at enrollment or postmenopausal for at least 1 year * No major clinical disease (e.g., diabetes, cardiovascular, liver or chronic kidney disease) to minimize confounding of vascular measures * Participants will be sedentary (≤3x per week of ≤30 minutes of aerobic exercise/session) or trained (≥5x per week of moderate/vigorous aerobic exercise training)

Exclusion criteria

* Age \<20 or 31 to 49 or \>60 years * Body mass index ≥30 kg/m\^2 because obesity may affect vascular function * Use of medication that may affect vascular measures * Hormone replacement therapy or hormonal contraceptives within past year * Use of tobacco products (chewing tobacco, traditional or e-cigarettes) because they may influence vascular function * Being perimenopausal, pregnant or lactating because may influence vascular function * Being a shift worker because habitual sleep deprivation and altered circadian rhythm may influence vascular function. * Not having an intermediate chronotype based on the Morningness-Eveningness Questionnaire (MEQ; score \<31 or \>69) because this would influence the effect of overnight sleep deprivation on vascular function. * Sleep complaints based on the Pittsburgh Sleep Quality Index (PSQI; score \>5) because this would influence the effect of overnight sleep deprivation on vascular function.

Design outcomes

Primary

MeasureTime frameDescription
Endothelial functionthrough study completion, an average of 1 monthEndothelial function will be determined using brachial artery flow-mediated dilation via high resolution duplex ultrasonography. Reactive hyperemia will be produced by inflating a forearm cuff to \ 250 mmHg for 5 minutes followed by rapid deflation.
Microvascular functionthrough study completion, an average of 1 monthMicrovascular function will be assessed using the forearm blood flow response to submaximal handgrip exercise. Brachial artery blood flow and diameter will be assessed using Doppler ultrasound.

Secondary

MeasureTime frameDescription
Central arterial stiffnessthrough study completion, an average of 1 monthThe SphygmoCor XCEL device will be used to measure carotid to femoral pulse wave velocity.
Central arterial hemodynamicsthrough study completion, an average of 1 monthThe SphygmoCor XCEL device will be used to obtain central pulse wave analysis.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026